Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R2630 Gly-Arg 231.25 C8H17N5O3
R2631 Val-Ser 204.22 C8H16N2O4
R2632 PLP (180–199) 2085.3 C92H145N23O30S
R2633 H-Lys-Lys-Glu-Thr-Leu-Gln-Phe-Arg-OH 1049.2 C47H80N14O13
R2634 Guanylin (rat, mouse) 1515.7 C60H90N16O22S4
R2635 MM 07 1539.9 C67H106N22O14S3
R2636 [Leu³]-Oxytocin 1007.2 C43H66N12O12S2
R2637 Abz-Val-Ala-Asp-Nva-Arg-Asp-Arg-Gln-EDDnp 1285.3 C53H80N20O18
R2638 Carbobenzoxy-l-alanyl-alanyl-asparagine 408.4 C18H24N4O7
R2639 MC-Gly-Gly-Phe 472.5 C23H28N4O7
R2640 (Des-ala3)-ghrp-2 746.9 C42H50N8O5
R2641 Thrombospondin (TSP-1)-derived CD36 binding motif 566.7 C20H34N6O9S2
R2642 (Ser(Ac)3)-Ghrelin (mouse, rat) 3230.6 C141H233N45O42
R2643 Mal-amido-PEG2-Val-Cit-PAB-PNP 854.9 C39H50N8O14
R2644 (arg8,des-Gly-NH29)-vasopressin 1028.2 C44H61N13O12S2
R2645 [Tyr38,Phe42,46]-Osteocalcin (38-49) (human) 1516.7 C73H101N19O17
R2646 Dihydrosomatostatin 1639.9 C76H106N18O19S2
R2647 Pyr3]-Amyloid β-Protein (3-42) 4310 C196H299N53O55S
R2648 Hel 13-5 (Pulmonary Surfactant Model Peptide) 311.4 C20H25NO2
R2649 Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) Trifluoroacetate 683.6 C24H36F3N9O11